GLG Topic: Neurology
Neurology is the field of medicine concerning the diagnosis, delineation, and treatment of disorders and diseases of the nervous system. Common neurological disorders include depression, epilepsy, anxiety, sleep disorders, and schizophrenia. Examples of common neurological diseases include Parkinson's, Huntington's, and Alzheimer's.
Request a consultation
Leading Experts: Neurology
![]() |
What is a GLG Leader? |
Associate Professor and Director
MOUNT SINAI SCHOOL OF MEDICINE
Joseph Friedman, MD, is the Director of Clinical Neuroscience Center and Associate Professor of Psychiatry at the Mount Sinai School of Medicine in New York. He has expertise in the treatment of schizophrenia and Alzheimer's disease and is noted for clinical trials work in schizophrenia and Alzheimer's...
Daniel Wynn, MDDirector, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
B. Michael Silber, PHDChief of Drug Discovery R & D
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
Michael Silber, PhD, is Chief of Drug Discovery R & D and Adjunct Professor of Neurology and Biopharmaceutical Sciences, Institute for Neurodegenerative Diseases, at UCSF Medical School. He has over 25 years of expertise in all aspects of Pharma and Biotech R & D and API and biologics manufacturing,...
Jason Campagna, MD,PhDDirector of Clinical Quality and Analytics
COTTAGE HEALTH SYSTEM
Jason Campagna, MD, PhD, is an Anesthesiologist in Santa Barbara, California and the Director of Center for Clinical Quality and Analytics at Cottage Health System. He also holds a faculty appointment at Neuroscience Research Institute at UC Santa Barbara, and serves as the Director of Center for Applied...
President and Chief Executive Officer
AciesHealth
Mark Capriani, MBA, is the President and Chief Executive Officer of AciesHealth, a specialty pharmaceutical company in Pennsylvania. He has over 15 years of experience in pharmaceutical industry including biotech, branded and multi source pharmaceuticals, consumer products, device, and wound and burn...
Study Groups: Neurology(?)
| Study Group Name | Members |
|---|---|
| Neurology Devices Distributors | 30 |
| Physicians who Treat Neuropathy (US) | 75 |
| Clozaril Prescribers (US) | 38 |
| Critical Care Physicians (US) | 47 |
| Lexapro Prescribers: Psychiatrists (US) | 62 |
GLG NewsSM
Analysis: Neurology(?)
Copaxone has become the leading treatment for relapsing remitting MS in the US. The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.
Abbott’s Neuronal Nicotinic Receptor (NNR) partial agonist platform is an innovative target for ADHD and potentially other CNS disorders. The Phase II data on ABT-089 suggests efficacy for adult ADHD with good safety/tolerability. NNRs will not have the kind of effect size seen with stimulants...
The American Academy of Neurology announced that Vitamin E holds substantial health benefits for Alzheimer's sufferers. These findings may increase demand for supplemental Vitamin E. Vitamin E producers have recently increased prices, primarily, due to exploding feedstock demand. In...
GLG InstituteSM
Seminars: Neurology(?)
Recent Seminars
Quick Facts about GLG
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms


